May 13, 2022 — On Wednesday, May 11th the Miami Cancer Institute Pharmacy Team was awarded the 2022 Warren E. Weaver/Richard P. Penna Award by the Board of Pharmacy Specialties (BPS). Presented at Miami Cancer Institute, part of Baptist Health South Florida, the award recognizes individuals and patient care organizations for advancing health quality and patient care, according to the BPS.
“We are thrilled to receive the Weaver/Penna Award in recognition of the Miami Cancer Institute pharmacy team’s diligent commitment to the profession and our patients,” said Dr. Madeline Camejo, chief pharmacy officer at Baptist Health South Florida. “Our pharmacy team has a wealth of experience that is critical to the Institute’s day-to-day activities. Additionally, the team has the drive to maintain a certification that encourages the long-term development of evidence-based practices.”
The oncology pharmacy team at Miami Cancer Institute, led by Jorge J. García, PharmD, Assistant Vice President of System Oncology Pharmacy Services, has 32 board-certified pharmacists, 10 of whom are dual certified, according to Dr. Camejo. The pharmacists, she says, are fully integrated into the care of each and every patient at the Institute.
The Miami Cancer Institute pharmacy team is internally motivated to be the best for the patients they serve. Additionally, the team is motivated to be active within professional organizations at the local, state, and national levels. The pharmacy team has participated in over 50 presentations, 20 publications and research posters, and staff have held numerous leadership positions in pharmacy and cancer organizations over the past three years.
According to the BPS, board certification is a recognized credential for determining which pharmacists are qualified to contribute at advanced practice levels given the rigorous standards mandated by BPS board certification and recertification. The BPS says it currently recognizes more than 54,400 active pharmacist certifications across 14 specialties.
About Miami Cancer Institute
Miami Cancer Institute brings to South Florida access to personalized clinical treatments and comprehensive support services delivered with unparalleled compassion. No other cancer program in the region has the combination of cancer-fighting expertise and advanced technology—including the first proton therapy center in South Florida, Latin America and the Caribbean, and one of the only radiation oncology programs in the world with each of the newest radiation therapies in one place—to diagnose and deliver precise cancer treatments that achieve the best outcomes and improve the lives of cancer patients. The Institute offers an impressive roster of established community oncologists and renowned experts, clinical researchers and genomic scientists recruited from the nation’s top cancer centers. Selected as Florida’s only member of the Memorial Sloan Kettering Cancer (MSK) Alliance, Miami Cancer Institute is part of a meaningful clinical collaboration that affords patients in South Florida access to innovative treatments and ensures that the standards of care developed by their multidisciplinary disease management teams match those at MSK.
About the Board of Pharmacy Specialties
The Board of Pharmacy Specialties (BPS) was established in 1976 as an autonomous division of the American Pharmacists Association (APhA). The mission of BPS is to improve patient care by positioning BPS Board-Certified Pharmacist Specialists as integral members of interprofessional healthcare teams, through recognition and promotion of specialized training, knowledge, and skills for pharmacists in the United States and internationally. Board certification is a recognized credential for determining which pharmacists are qualified to contribute at advanced practice levels given the rigorous standards mandated by BPS board certification and recertification. BPS currently recognizes more than 54,400 active pharmacist certifications across 14 specialties.
